Cargando…
Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study
BACKGROUND: Accumulation of epicardial fat (EF) is associated with increased cardio-metabolic risks and coronary events, independently of traditional cardiovascular risk factors. Therefore, the reduction of EF volume (EFV) may be associated with reduced cardio-metabolic risks and future cardiovascul...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5335851/ https://www.ncbi.nlm.nih.gov/pubmed/28253918 http://dx.doi.org/10.1186/s12933-017-0516-8 |